Suppr超能文献

使用 HeartMate 3 左心室辅助装置进行长期支持的泵参数的纵向分析。

Longitudinal analysis of pump parameters over long-term support with the HeartMate 3 left ventricular assist device.

机构信息

Università Vita Salute San Raffaele, Milano.

Department of Anesthesia and Intensive Care, Cardiothoracic Intensive Care Unit, IRCCS San Raffaele Scientific Institute, Milan.

出版信息

J Cardiovasc Med (Hagerstown). 2023 Oct 1;24(10):771-775. doi: 10.2459/JCM.0000000000001522. Epub 2023 Jun 30.

Abstract

AIMS

Recurrence of heart failure emerged as the main cause of long-term mortality in patients implanted with the HeartMate 3 (HM3) left ventricular assist device (LVAD). We aimed at deriving a possible mechanistic rationale of clinical outcomes and analyzed longitudinal changes in pump parameters over prolonged HM3 support to investigate long-term effects of pump settings on left ventricular mechanics.

METHODS

Data on pump parameters (i.e. pump speed, estimated flow, and pulsatility index) were prospectively recorded in consecutive HM3 patients following postoperative rehabilitation (baseline) and then at 6, 12, 24, 36, 48, and 60 months of support.

RESULTS

Data of 43 consecutive patients were analyzed. Pump parameters were set according to regular patients' follow-up, including clinical and echocardiographic assessment. We recorded a significant progressive increase in pump speed over the course of support: from 5200 (5050-5300) rpm at baseline to 5400 (5300-5600) rpm at 60 months of support ( P  = 0.0007). Consistently with the increase in pump speed, a significant increase in pump flow ( P  = 0.007) and a decrease in pulsatility index ( P  = 0.005) were also recorded.

CONCLUSION

Our results reveal unique features of the HM3 on left ventricular activity. The need for progressive increase in pump support suggests indeed a lack of recovery and worsening of left ventricular function, which emerge as a possible mechanistic rationale of heart failure related mortality in HM3 patients. New algorithms to optimize pump settings should be envisioned to further improve LVAD-LV interaction and, ultimately, clinical outcomes in the HM3 population.

CLINICAL TRIAL REGISTRATION

https://clinicaltrials.gov/ct2/show/NCT03255928.

CLINICALTRIALSGOV IDENTIFIER

NCT03255928.

摘要

目的

心力衰竭的复发是植入 HeartMate 3(HM3)左心室辅助装置(LVAD)患者长期死亡的主要原因。我们旨在得出临床结果的可能机制原理,并分析在 HM3 支持下延长时间内泵参数的纵向变化,以研究泵设置对左心室力学的长期影响。

方法

在 HM3 患者术后康复(基线)后,以及在支持的 6、12、24、36、48 和 60 个月时,前瞻性记录泵参数(即泵转速、估计流量和脉动指数)的数据。

结果

分析了 43 例连续 HM3 患者的数据。泵参数是根据常规患者随访设置的,包括临床和超声心动图评估。我们记录到随着支持时间的推移,泵转速显著增加:从基线时的 5200(5050-5300)转/分增加到 60 个月时的 5400(5300-5600)转/分(P=0.0007)。与泵转速的增加一致,泵流量也显著增加(P=0.007),脉动指数降低(P=0.005)。

结论

我们的结果揭示了 HM3 对左心室活动的独特特征。需要逐渐增加泵的支持,这确实表明左心室功能没有恢复,而且在恶化,这可能是 HM3 患者心力衰竭相关死亡率的机制原理。应该设想新的算法来优化泵的设置,以进一步改善 LVAD-LV 相互作用,并最终改善 HM3 人群的临床结果。

临床试验注册

https://clinicaltrials.gov/ct2/show/NCT03255928.

临床试验标识符

NCT03255928.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验